Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Appointed director
|
|
Ocuphire Pharma, Inc. (OCUP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/06/2020 |
8-K
| Investor presentation, Director compensation was amended/approved, Acquisition/merger/asset purchase announced|
Docs:
|
"Certificate of Amendment (Reverse Stock Split) to the Certificate of Incorporation of the Company",
"Certificate of Amendment (Name Change) to the Certificate of Incorporation of the Company",
"Second Amended and Restated Bylaws of the Company",
"Contingent Value Rights Agreement, by and among the Company, Shareholder Representative Services LLC and the Olde Monmouth Stock Transfer Co., Inc",
"INDEMNITY AGREEMENT",
"1. Annual Board Service Retainer: All Eligible Directors: $40,000 Chair of the Board : $35,000 Lead Independent Director : $20,000 2. Annual Committee Member Service Retainer: Member of the Audit Committee: $7,500 Member of the Compensation Committee: $5,000 Member of the Nominating and Corporate Governance Committee: $4,000 1",
"Code of Business Conduct and Ethics of the Company",
"Letter from Baker Tilly",
"About Ocuphire Pharma",
"Ocuphire Corporate Presentation" |
|
| 06/19/2020 |
8-K
| Quarterly results |
|
|